Your browser doesn't support javascript.
loading
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
Horgan, Denis; Curigliano, Giuseppe; Rieß, Olaf; Hofman, Paul; Büttner, Reinhard; Conte, Pierfranco; Cufer, Tanja; Gallagher, William M; Georges, Nadia; Kerr, Keith; Penault-Llorca, Frédérique; Mastris, Ken; Pinto, Carla; Van Meerbeeck, Jan; Munzone, Elisabetta; Thomas, Marlene; Ujupan, Sonia; Vainer, Gilad W; Velthaus, Janna-Lisa; André, Fabrice.
Afiliação
  • Horgan D; European Alliance for Personalised Medicine, Avenue de l'Armee/Legerlaan 10, 1040 Brussels, Belgium.
  • Curigliano G; European Institute of Oncology, IRCCS, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy.
  • Rieß O; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono, 7, 20122 Milan, Italy.
  • Hofman P; Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Calwerstrasse 7, 72070 Tuebingen, Germany.
  • Büttner R; Laboratory of Clinical and Experimental Pathology, University of Côte d'Azur, FHU OncoAge, Biobank BB-0033-00025, Pasteur Hospital, 30 Avenue de la voie Romaine, CEDEX 01, 06001 Nice, France.
  • Conte P; Institute for Pathology, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
  • Cufer T; The Veneto Institute of Oncology, IRCCS, Via Gattamelata, 64, 35128 Padua, Italy.
  • Gallagher WM; Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Via Giustiniani, 2, 35124 Padua, Italy.
  • Georges N; Medical Faculty, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.
  • Kerr K; School of Biomolecular and Biomedical Science, University College Dublin, Belfield, D04 V1W8 Dublin, Ireland.
  • Penault-Llorca F; Exact Sciences, Quai du Seujet 10, 1201 Geneva, Switzerland.
  • Mastris K; School of Medicine and Dentistry, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.
  • Pinto C; Centre Jean Perrin, 58, Rue Montalembert, CEDEX 01, 63011 Clermont-Ferrand, France.
  • Van Meerbeeck J; Department of Pathology, University of Clermont Auvergne, INSERM U1240, 49 bd François Mitterrand, CS 60032, 63001 Clermont-Ferrand, France.
  • Munzone E; Europa Uomo, Leopoldstraat 34, 2000 Antwerp, Belgium.
  • Thomas M; AstraZeneca, Rua Humberto Madeira 7, 1800 Oeiras, Portugal.
  • Ujupan S; Antwerp University Hospital, University of Antwerp, Wijlrijkstraat 10, 2650 Edegem, Belgium.
  • Vainer GW; European Institute of Oncology, IRCCS, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy.
  • Velthaus JL; F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.
  • André F; Eli Lilly and Company, Rue du Marquis 1, Markiesstraat, 1000 Brussels, Belgium.
J Pers Med ; 12(1)2022 Jan 08.
Article em En | MEDLINE | ID: mdl-35055387
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: J Pers Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: J Pers Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica